In a filing, Ocular Therapeutix Inc revealed its Chief Strategy Officer Nayak Sanjay unloaded Company’s shares for reported $16525.0 on Aug 23 ’24. In the deal valued at $9.02 per share,1,832 shares were sold. As a result of this transaction, Nayak Sanjay now holds 176,194 shares worth roughly $-1.84 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Dugel Pravin sold 20,880 shares, generating $188,338 in total proceeds. Upon selling the shares at $9.02, the insider now owns 812,473 shares.
Before that, RABIA OZDEN bought 18,333 shares. Ocular Therapeutix Inc shares valued at $164,997 were divested by the Officer at a price of $9.00 per share.
TD Cowen upgraded its Ocular Therapeutix Inc [OCUL] rating to a Buy from a a Hold in a research note published on June 20, 2024; the price target was increased to $11 from $7. BofA Securities began covering OCUL with “Buy” recommendation on February 09, 2024. Robert W. Baird started covering the stock on April 21, 2023. It rated OCUL as “an Outperform”.
Price Performance Review of OCUL
On Monday, Ocular Therapeutix Inc [NASDAQ:OCUL] saw its stock jump 6.95% to $10.46. Over the last five days, the stock has gained 10.34%. Ocular Therapeutix Inc shares have risen nearly 134.53% since the year began. Nevertheless, the stocks have risen 313.44% over the past one year. While a 52-week high of $11.31 was reached on 03/06/24, a 52-week low of $2.00 was recorded on 01/19/24. SMA at 50 days reached $8.76, while 200 days put it at $7.27.
Levels Of Support And Resistance For OCUL Stock
The 24-hour chart illustrates a support level at 9.90, which if violated will result in even more drops to 9.33. On the upside, there is a resistance level at 10.77. A further resistance level may holdings at 11.07. The Relative Strength Index (RSI) on the 14-day chart is 70.44, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.53, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 2.48%. Stochastics %K at 77.81% indicates the stock is a holding.
How much short interest is there in Ocular Therapeutix Inc?
A steep rise in short interest was recorded in Ocular Therapeutix Inc stocks on 2024-09-30, dropping by -2.16 million shares to a total of 16.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 18.35 million shares. There was a decline of -13.32%, which implies that there is a negative sentiment for the stock.
